Clinical Trials Logo

Clinical Trial Summary

Evaluation of the effect of tegaserod treatment on small intestinal motility and flow pattern in female IBS-C patients.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00171431
Study type Interventional
Source Novartis
Contact
Status Terminated
Phase Phase 3
Start date November 2004
Completion date May 2006